2024

1. Accurate identification of locally aneuploid cells by incorporating cytogenetic information in single cell data analysis

   Scientific Reports, Vol. 14, Núm. 1

2. Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax

   Clinical Cancer Research, Vol. 30, Núm. 7, pp. 1319-1326

3. Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes

   Nature Communications, Vol. 15, Núm. 1

4. Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma

   Nature Communications, Vol. 15, Núm. 1

5. Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia

   Cell Reports Medicine, Vol. 5, Núm. 6